Trigyn Technologies Intrinsic Value
Trigyn Technologies (TRIGYN) median intrinsic value is ₹68.03 from 8 valuation models (range ₹16–₹134), vs current price ₹53.56 — +27.0% upside (Trading Below Calculated Value), margin of safety 21.3%. See TRIGYN book value to compare market price against book value per share.
TRIGYN Valuation Methods Summary — DCF, Graham Number & P/E
Trigyn Technologies intrinsic value across 8 models vs current price ₹53.56 — upside/downside and value range per method. For current market price and key ratios, visit Trigyn Technologies stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹16.07 | ₹12.86 - ₹19.28 | -70.0% | EPS: ₹0.80, Sector P/E: 12x |
| Book Value Method | asset | ₹133.90 | ₹120.51 - ₹147.29 | +150.0% | Book Value/Share: ₹257.10, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹107.12 | ₹96.41 - ₹117.83 | +100.0% | Revenue/Share: ₹330.32, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹61.94 | ₹55.75 - ₹68.13 | +15.6% | EBITDA: ₹32.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹133.90 | ₹107.12 - ₹160.68 | +150.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹16.07 | ₹14.46 - ₹17.68 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹16.07 | ₹14.46 - ₹17.68 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹68.03 | ₹61.23 - ₹74.83 | +27.0% | EPS: ₹0.80, BVPS: ₹257.10 |
TRIGYN Intrinsic Value vs Market Price — All Valuation Models
Trigyn Technologies fair value range ₹16–₹134 vs current market price ₹53.56 across 8 valuation models. Check Trigyn Technologies marketcap in USD to track the company's total market size over time.
TRIGYN Intrinsic Value Analysis — Undervalued or Overvalued?
Trigyn Technologies median intrinsic value ₹68.03, current price ₹53.56 — Trading Below Calculated Value by 27.0%, margin of safety 21.3%.
What is the intrinsic value of TRIGYN?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Trigyn Technologies (TRIGYN) is ₹68.03 (median value). With the current market price of ₹53.56, this represents a +27.0% variance from our estimated fair value.
The valuation range spans from ₹16.07 to ₹133.90, indicating ₹16.07 - ₹133.90.
Is TRIGYN undervalued or overvalued?
Based on our multi-method analysis, Trigyn Technologies (TRIGYN) appears to be trading below calculated value by approximately 27.0%.
TRIGYN Financial Health — Key Ratios vs Industry Benchmarks
Trigyn Technologies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 49.38 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 0.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.04x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
TRIGYN Cash Flow Quality — Operating & Free Cash Flow
Trigyn Technologies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹52 Cr | ₹52 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹126 Cr | ₹126 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-52 Cr | ₹-63 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹45 Cr | ₹35 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹80 Cr | ₹76 Cr | Positive Free Cash Flow | 8/10 |